Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs Harbor

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Harbor a 75. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

Harbor

#128 · Grade C+ · Fair Price

Est. first month

From $99/mo (starting dose, compounded)

Save ~93% vs brand-name
Get this deal Full Harbor review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 75 an est. $99/mo first month, with no teaser step-up baked in. Harbor isn't out of it: Shoppers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsHarbor
Value Score90 (A)75 (C+)
Est. first month$99/moFrom $99/mo (starting dose, compounded)
Save vs brand-name~93%~93%
Semaglutide$99/moFrom $99/mo (starting dose, compounded)
Tirzepatide$145/moFrom $149/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
90
Alan Meds: 95. Harbor: 90.
85
No Teaser-Rate Bait
64
Alan Meds: 85. Harbor: 64.
98
Nationwide Availability
45
Alan Meds: 98. Harbor: 45.
94
Both Molecules
92
Alan Meds: 94. Harbor: 92.
82
Easy Cancellation
58
Alan Meds: 82. Harbor: 58.
72
Reputation
78
Alan Meds: 72. Harbor: 78.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

Harbor

Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Why it's a deal

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

The fine print

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified
Get the Alan Meds deal Get the Harbor deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Harbor.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.